The Australian Competition and Consumer Commission has accepted an "administrative undertaking" from Chemmart in relation to representations around the myDNA genetic test.
The ACCC says it was concerned that statements in the pharmacy group's catalogues, in-store brochures and TV informercials about the myDNA test could convey a "false or misleading impression regarding the usefulness of the genetic test and the consumers for whom it may be appropriate".
The myDNA test is claimed to identify an individual's response to certain drugs, with the ACCC saying a patient's genetic profile is "just one of a wide range of factors that may be considered by a medical practitioner in determining the type and dose of drug that is suitable".
Chemmart withdrew all of the promotional materials after it was contacted by the ACCC and agreed to refrain from making any potentially misleading statements about the myDNA test.
ACCC commissioner Sarah Court said "this is a reminder to pharmacies to avoid making statements about products in advertising and promotional materials that are overly broad".
The above article was sent to subscribers in Pharmacy Daily's issue from 12 Sep 16
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 12 Sep 16